基于Cas10的7SL-sRNA诊断,用于检测活跃的试相异性
Sabine Grüschow1, Pieter C Steketee2, Edith Paxton2
1School of Biology, University of St Andrews, St Andrews, United Kingdom.
PLoS neglected tropical diseases
|March 17, 2025
概括
新的诊断测试检测了动物三生病 (AT) 感染的牛中的特定小RNA (7SL-sRNA). 这一突破使得现场部署可检测的活跃感染,即使在慢性阶段.
科学领域:
- 兽医医学 兽医医学 兽医医学
- 分子诊断学 分子诊断学
- 寄生虫学的寄生虫学
背景情况:
- 在非洲,拉丁美洲和亚洲,动物三索马症 (AT) 严重影响了牛群,造成了巨大的经济损失.
- 目前的诊断缺乏,导致过度依赖药物治疗和药物耐药性的增加.
- 检测慢性AT感染是具有挑战性的,因为寄生虫水平较低,需要现场适用的测试.
研究的目的:
- 开发用于动物松症 (AT) 的现场部署的诊断测试.
- 在受感染的牛血清中检测寄生虫特定的小RNA (7SL-sRNA).
- 利用Cas10技术进行敏感和特定的sRNA检测.
主要方法:
- 使用Cas10技术开发一种基于光的测定方法.
- 使用Cas10技术开发横流诊断测试.
- 在牛血清中检测Trypanosoma congolense和Trypanosoma brucei 7SL-sRNA.
主要成果:
- 光测定检测到7SL-sRNA在T.congolense和T.brucei的女性粒度 (fM) 和小粒度 (pM) 度.
- 侧向流量试验显示,这两种物种的检测极限为1-10 pM.
- 这两种测定都成功地确定了活跃的AT感染,包括在感染后63天的慢性阶段.
结论:
- Cas10技术有效检测小RNA,包括7SL-sRNA.
- 开发的测定方法为AT提供了成本效益高,用户友好和现场部署的诊断工具.
- 这项工作为一般小RNA检测建立了Cas10,并为AT管理提供了至关重要的工具.
相关概念视频
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:22American Trypanosomiasis
Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...